Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency
Philip G. Murray, … , Pierre Chatelain, Peter E. Clayton
Philip G. Murray, … , Pierre Chatelain, Peter E. Clayton
Published April 5, 2018
Citation Information: JCI Insight. 2018;3(7):e93247. https://doi.org/10.1172/jci.insight.93247.
View: Text | PDF
Clinical Medicine Endocrinology

Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency

  • Text
  • PDF
Abstract

BACKGROUND. The effect of gene expression data on diagnosis remains limited. Here, we show how diagnosis and classification of growth hormone deficiency (GHD) can be achieved from a single blood sample using a combination of transcriptomics and random forest analysis. METHODS. Prepubertal treatment-naive children with GHD (n = 98) were enrolled from the PREDICT study, and controls (n = 26) were acquired from online data sets. Whole blood gene expression was correlated with peak growth hormone (GH) using rank regression and a random forest algorithm tested for prediction of the presence of GHD and in classification of GHD as severe (peak GH <4 μg/l) and nonsevere (peak ≥4 μg/l). Performance was assessed using area under the receiver operating characteristic curve (AUC-ROC). RESULTS. Rank regression identified 347 probe sets in which gene expression correlated with peak GH concentrations (r = ± 0.28, P < 0.01). These 347 probe sets yielded an AUC-ROC of 0.95 for prediction of GHD status versus controls and an AUC-ROC of 0.93 for prediction of GHD severity. CONCLUSION. This study demonstrates highly accurate diagnosis and disease classification for GHD using a combination of transcriptomics and random forest analysis. TRIAL REGISTRATION. NCT00256126 and NCT00699855. FUNDING. Merck and the National Institute for Health Research (CL-2012-06-005).

Authors

Philip G. Murray, Adam Stevens, Chiara De Leonibus, Ekaterina Koledova, Pierre Chatelain, Peter E. Clayton

×
Options: View larger image (or click on image) Download as PowerPoint
Prediction of GH severity (peak GH ≤4 μg/l or &gt;4 μg/l) via random for...

Prediction of GH severity (peak GH ≤4 μg/l or >4 μg/l) via random forest model


Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts